https://doi.org/10.4081/monaldi.2021.1802
Very late stent thrombosis associated with COVID-19 infection: a case report and review of the literature
Submitted: February 9, 2021
Accepted: August 11, 2021
Published: September 16, 2021
Accepted: August 11, 2021
Abstract Views: 1511
PDF: 680
Video 1: 193
Video 2: 160
Video 3: 176
Video 4: 162
Video 5: 180
Video 1: 193
Video 2: 160
Video 3: 176
Video 4: 162
Video 5: 180
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 has varied manifestation with multisystem involvement. Acute coronary syndrome in COVID-19 as a result of stent thrombosis is an uncommon entity and is often due to hypercoagulable state. A 40-year-old male was referred to us with acute onset chest pain. He also reported fever, sore throat and dry cough for six days which mandated testing for COVID-19 which turned out to be positive. He had a prior history of coronary artery disease with a drug eluting stent implanted two years back. An electrocardiogram was suggestive of acute anterior wall myocardial infarction while echocardiogram revealed hypokinesia of left anterior descending (LAD) artery territory. Coronary angiogram revealed non-occlusive thrombus in proximal LAD stent. A Thrombolysis in Myocardial Infarction (TIMI) III flow was restored following balloon angioplasty with a non-compliant balloon and use of glycoprotein (GP) IIb-IIIa receptor antagonist. A diagnosis of very late stent thrombosis subsequent to COVID-19 was made.
Kunal S, Gupta K, Sharma SM, et al. Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Arch Chest Dis 2020;90:1305.
DOI: https://doi.org/10.4081/monaldi.2020.1305
Claessen BE, Henriques JP, Jaffer FA, et al. Stent thrombosis: a clinical perspective. JACC Cardiovasc Interv 2014;7:1081-92.
DOI: https://doi.org/10.1016/j.jcin.2014.05.016
Cutlip DE, Nakazawa G, Krucoff MW, et al. Autopsy validation study of the academic research consortium stent thrombosis definition. JACC Cardiovasc Interv 2011;4:554-9.
DOI: https://doi.org/10.1016/j.jcin.2011.01.011
Wang X, Chen X, Sun W, et al. Very late stent thrombosis in drug-eluting stents new observations and clinical implications. Cardiol Rev 2019;27:279-85.
DOI: https://doi.org/10.1097/CRD.0000000000000283
Wang X, Chen X, Tian T, et al. A scoring system to predict the occurrence of very late stent thrombosis following percutaneous coronary intervention for acute coronary syndrome. Sci Rep 2020;10:6378.
DOI: https://doi.org/10.1038/s41598-020-63455-0
Waksman R, Kirtane AJ, Torguson R, et al. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis). JACC Cardiovasc Interv 2014;7:1093-102.
DOI: https://doi.org/10.1016/j.jcin.2014.04.017
Del Pace S, Boddi M, Rasoini R, et al. Acute infection-inflammation and coronary stent thrombosis: an observational study. Intern Emerg Med 2010;5:121-6.
DOI: https://doi.org/10.1007/s11739-010-0350-4
Abou-Ismail MY, Diamond A, Kapoor S, et al. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res 2020;194:101-15.
DOI: https://doi.org/10.1016/j.thromres.2020.06.029
Kunal S, Bhatia H, Sharma SK, et al. Pulmonary thromboembolism in COVID-19: initial experience from India. J Clin Diagn Res 2020;14:OD05-OD07.
DOI: https://doi.org/10.7860/JCDR/2020/45723.13987
Choudry FA, Hamshere SM, Rathod KS, et al. High thrombus burden in patients with COVID-19 presenting with ST-elevation myocardial infarction. J Am Coll Cardiol 2020; 6:1168-76.
DOI: https://doi.org/10.1016/j.jacc.2020.07.022
Antuña P, Rivero F, Del Val D, et al. Late coronary stent thrombosis in a patient with Coronavirus Disease 2019. JAMA Cardiol 2020;5:1195-8.
DOI: https://doi.org/10.1001/jamacardio.2020.2459
Hinterseer M, Zens M, Wimmer RJ, et al. Acute myocardial infarction due to coronary stent thrombosis in a symptomatic COVID-19 patient. Clin Res Cardiol 2021;110:302-6.
DOI: https://doi.org/10.1007/s00392-020-01663-4
Galeazzi GL, Loffi M, Di Tano G, Danzi GB. Severe COVID-19 pneumonia and very late stent thrombosis: a trigger or innocent bystander? Korean Circ J 2020;50:632-3.
DOI: https://doi.org/10.4070/kcj.2020.0166
Prieto-Lobato A, Ramos-Martínez R, Vallejo-Calcerrada N, et al. A case series of stent thrombosis during the COVID-19 pandemic. JACC Case Rep 2020;2:1291-6.
DOI: https://doi.org/10.1016/j.jaccas.2020.05.024
Naderi N, Ansari Ramandi MM, Baay M, et al. Cardiovascular patients in COVID-19 era, a case series, an experience from a tertiary cardiovascular center in Tehran, Iran. Clin Case Rep 2020;8:2436-42.
DOI: https://doi.org/10.1002/ccr3.3163
Lacour T, Semaan C, Genet T, Ivanes F. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients. Catheter Cardiovasc Interv 2021;97:E241-3.
DOI: https://doi.org/10.1002/ccd.28948
Ayan M, Kovelamudi S, Al-Hawwas M. Subacute stent thrombosis in a patient with COVID-19 pneumonia. Proc (Bayl Univ Med Cent) 2020;34:175-7.
DOI: https://doi.org/10.1080/08998280.2020.1812792
How to Cite
Kunal, Shekhar, Vijay Pathak, Keshav Pathak, Monika Mishra, Shashi Mohan Sharma, and Sudhir Bhandari. 2021. “Very Late Stent Thrombosis Associated With COVID-19 Infection: A Case Report and Review of the Literature”. Monaldi Archives for Chest Disease 92 (2). https://doi.org/10.4081/monaldi.2021.1802.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Marco Ambrosetti, Patrick Doherty, Pompilio Faggiano, Ugo Corrà, Carlo Vigorito, Dominique Hansen, Patrizio Sarto, Ana Abreu, Roberto F.E. Pedretti, Characteristics of structured physical training currently provided in cardiac patients: insights from the Exercise Training in Cardiac Rehabilitation (ETCR) Italian survey , Monaldi Archives for Chest Disease: Vol. 87 No. 1 (2017)
- Benhur Joel Shadrach, Rishabh Goel, Kunal Deokar, Anukool Jain, Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Anu Anna George, Kevin John John, Vijairam Selvaraj, Ajay Kumar Mishra, Endocrinological abnormalities and Takotsubo cardiomyopathy , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Elena Bargagli, Viola Bonti, Alessandra Bindi, Vieri Scotti, Massimo Pistolesi, Luca Voltolini, Katia Ferrari, Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer , Monaldi Archives for Chest Disease: Vol. 88 No. 2 (2018)
- Nicola Barbarito, A strange case of severe but fleeting hypoxemia in patient with COVID-19 infection: maybe virus-induced pulmonary Raynaud’s phenomenon? , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
You may also start an advanced similarity search for this article.
